nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Priapism—Riluzole—amyotrophic lateral sclerosis	0.0533	0.0533	CcSEcCtD
Alfuzosin—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.0393	0.0393	CcSEcCtD
Alfuzosin—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.0357	0.0357	CcSEcCtD
Alfuzosin—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.032	0.032	CcSEcCtD
Alfuzosin—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0306	0.0306	CcSEcCtD
Alfuzosin—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.0283	0.0283	CcSEcCtD
Alfuzosin—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0258	0.0258	CcSEcCtD
Alfuzosin—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0258	0.0258	CcSEcCtD
Alfuzosin—Injury—Riluzole—amyotrophic lateral sclerosis	0.0203	0.0203	CcSEcCtD
Alfuzosin—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0197	0.0197	CcSEcCtD
Alfuzosin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.0192	0.0192	CcSEcCtD
Alfuzosin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0187	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0171	0.0171	CcSEcCtD
Alfuzosin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0169	CcSEcCtD
Alfuzosin—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0157	CcSEcCtD
Alfuzosin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0155	CcSEcCtD
Alfuzosin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0149	CcSEcCtD
Alfuzosin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0144	CcSEcCtD
Alfuzosin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0144	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0141	CcSEcCtD
Alfuzosin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.014	0.014	CcSEcCtD
Alfuzosin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0138	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0136	CcSEcCtD
Alfuzosin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0135	CcSEcCtD
Alfuzosin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.013	0.013	CcSEcCtD
Alfuzosin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0128	CcSEcCtD
Alfuzosin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0128	CcSEcCtD
Alfuzosin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0127	CcSEcCtD
Alfuzosin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0127	CcSEcCtD
Alfuzosin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0121	CcSEcCtD
Alfuzosin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.012	0.012	CcSEcCtD
Alfuzosin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Alfuzosin—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Alfuzosin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Alfuzosin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0109	CcSEcCtD
Alfuzosin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0104	CcSEcCtD
Alfuzosin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0103	CcSEcCtD
Alfuzosin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0102	CcSEcCtD
Alfuzosin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Alfuzosin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Alfuzosin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00995	0.00995	CcSEcCtD
Alfuzosin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0099	0.0099	CcSEcCtD
Alfuzosin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00959	0.00959	CcSEcCtD
Alfuzosin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00959	0.00959	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00952	0.00952	CcSEcCtD
Alfuzosin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00947	0.00947	CcSEcCtD
Alfuzosin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00938	0.00938	CcSEcCtD
Alfuzosin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00919	0.00919	CcSEcCtD
Alfuzosin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00913	0.00913	CcSEcCtD
Alfuzosin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00904	0.00904	CcSEcCtD
Alfuzosin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00901	0.00901	CcSEcCtD
Alfuzosin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.009	0.009	CcSEcCtD
Alfuzosin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00897	0.00897	CcSEcCtD
Alfuzosin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00893	0.00893	CcSEcCtD
Alfuzosin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00888	0.00888	CcSEcCtD
Alfuzosin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00859	0.00859	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00837	0.00837	CcSEcCtD
Alfuzosin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00817	0.00817	CcSEcCtD
Alfuzosin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00809	0.00809	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00793	0.00793	CcSEcCtD
Alfuzosin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00792	0.00792	CcSEcCtD
Alfuzosin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00786	0.00786	CcSEcCtD
Alfuzosin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00786	0.00786	CcSEcCtD
Alfuzosin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00757	0.00757	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00751	0.00751	CcSEcCtD
Alfuzosin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0073	0.0073	CcSEcCtD
Alfuzosin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00726	0.00726	CcSEcCtD
Alfuzosin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00659	0.00659	CcSEcCtD
Alfuzosin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0065	0.0065	CcSEcCtD
Alfuzosin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00629	0.00629	CcSEcCtD
Alfuzosin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00608	CcSEcCtD
Alfuzosin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00584	CcSEcCtD
Alfuzosin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00579	0.00579	CcSEcCtD
Alfuzosin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00579	0.00579	CcSEcCtD
Alfuzosin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00576	CcSEcCtD
Alfuzosin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00546	0.00546	CcSEcCtD
